AzTrials
AzTrials

DysorthographiaPredict4AllNCT04210661

Spelling Mistake Tolerant Word Prediction for Working, Writing and Communicating

A study testing prediction software with spell checker in people with Dysorthographia and Neurologic Disorder, run by Centre d'Investigation Clinique et Technologique 805 at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of the PREDICT4ALL project is to provide written communication in a computer, reducing the number of spelling errors for each user. The effectiveness of written communication is defined in this study by the number of spelling errors for each user. Read more about this study

Who is it for?
Ages 6 to 25 years
Conditions the study is for
Dysorthographia, Neurologic Disorder
What is being tested?
prediction software with spell checker
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13 participants
Where
2 sitesFrance
Study dates
13 Feb 2020to 8 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Aged between 6 and 25 years old For center 1
  • patient with dysorthographia
  • educational level greater than or equal to CE2
  • A developmental level in reading on the Evalouette test (Evaleo battery) greater than or equal to CE1 For center 2
  • Neurologic disorder impacting communication

Who cannot join

  • Patient's refusal to participate in the study
  • Persons under guardianship
  • Pregnant women
  • No affiliation to a social security scheme (beneficiary or beneficiary)
  • Having visual disturbances preventing the use of the computer tool

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Raymond Poincaré hospital

    Garches, 92380

  • CMRRF Kerpape

    Ploemeur, 56270

Other trials in France

About this study

Official title: Spelling Mistake Tolerant Word Prediction for Working, Writing and Communicating - Predict4All

The main objective of the PREDICT4ALL project is to provide written communication in a computer, reducing the number of spelling errors for each user.

The effectiveness of written communication is defined in this study by the number of spelling errors for each user. Word prediction (and therefore correction) must be able to be configured by a therapist (speech therapist, occupational therapist).

Adapting the prediction to user errors should also allow it to be more relevant throughout the text input. This software efficiency must increase text input speed, Reduce the cognitive load, establish a classification of spelling errors adapted to the context of text input speed and develop the word prediction module tolerant of these spelling errors.

Being tested
prediction software with spell checker
Keywords
word prediction, dysorthographia
Medical subject headings
Nervous System Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • prediction software with spell checkerOther

    test with prediction software with spell checker

Study groups in NCT04210661
Study groupRoleWhat they receive
classic prediction softwareActive comparatortest with classic precition software
Receives: Other: prediction software with spell checker
prediction software with spell checkerExperimentaltest with prediction software with spell checker
Receives: Other: prediction software with spell checker

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of spelling errors

    total of number of spelling errors during the test

    Measured: 20 min

Secondary outcomes (6)
  1. Text input speed

    Text input speed in the test

    Measured: 20 min

  2. Prediction usage rate

    number of times the prediction is used

    Measured: 20 min

  3. Keystrokes Saving Rate

    measured by the percentage of input saved by word prediction versus a keyboard alone

    Measured: 5 min

  4. Attentional load

    Likert Analog Visual Scale [0-10]

    Measured: 1 min

  5. Fatigue

    Likert Analog Visual Scale [0-10]

    Measured: 1 min

  6. software Satisfaction

    Likert Analog Visual Scale [0-10]

    Measured: 1 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2019
  2. Study start13 Feb 2020
  3. Primary completion8 Mar 2022
  4. Study completion8 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Model description
interventionnal, prsopective, randomized, multicentric
Masking
None (open label)
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04210661
Sponsor's protocol ID
2019-A01882-55
Acronym
Predict4All
Status last verified
Feb 2022
First submitted
23 Dec 2019
Last updated
9 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing prediction software with spell checker in people with Dysorthographia and Neurologic Disorder, run by Centre d'Investigation Clinique et Technologique 805 at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of spelling errors (time frame: 20 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in